Growth Metrics

Rigel Pharmaceuticals (RIGL) Assets Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 59.82%
Dec 31, 2025 56.39%
Sep 30, 2025 28.01%
Jun 30, 2025 17.33%
Mar 31, 2025 5.69%
Dec 31, 2024 -0.67%
Sep 30, 2024 -9.25%
Jun 30, 2024 -13.96%
Mar 31, 2024 -16.33%
Dec 31, 2023 2.03%
Sep 30, 2023 -2.14%
Jun 30, 2023 -5.34%
Mar 31, 2023 -4.82%
Dec 31, 2022 -3.10%
Sep 30, 2022 -9.52%
Jun 30, 2022 -6.41%
Mar 31, 2022 -4.80%
Dec 31, 2021 6.35%
Sep 30, 2021 14.83%
Jun 30, 2021 12.60%
Mar 31, 2021 29.78%
Dec 31, 2020 -2.51%
Sep 30, 2020 19.98%
Jun 30, 2020 17.32%
Mar 31, 2020 12.26%
Dec 31, 2019 23.61%
Sep 30, 2019 20.75%
Jun 30, 2019 16.28%
Mar 31, 2019 16.86%
Dec 31, 2018 1.83%
Sep 30, 2018 -3.99%
Jun 30, 2018 -1.63%
Mar 31, 2018 -15.83%
Dec 31, 2017 -8.23%
Sep 30, 2017 -24.14%
Jun 30, 2017 -22.33%
Mar 31, 2017 -20.71%
Dec 31, 2016 -29.82%
Sep 30, 2016 -28.21%
Jun 30, 2016 -27.60%
Mar 31, 2016 -27.40%
Dec 31, 2015 -24.82%
Sep 30, 2015 -10.53%
Jun 30, 2015 -11.55%
Mar 31, 2015 -10.86%
Dec 31, 2014 -15.68%
Sep 30, 2014 -16.05%
Jun 30, 2014 -14.30%
Dec 31, 2013 6.58%